GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | 8/17/2026 8:05:15 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $1,101,000 | Assets $34,160,000 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/14/2026 4:53:53 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $1,101,000 | Assets $34,160,000 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/18/2026 7:01:43 AM | View | Financials | Earnings | WIRE | 1Q 2026 | Rev $1,068,000 | Assets $11,903,000 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/15/2026 4:45:14 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $1,068,000 | Assets $11,903,000 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 3/23/2026 4:45:24 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $1,225,000 | Assets $12,956,000 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 2/23/2026 5:02:32 PM | View | Proxy | SEC | |||||||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/17/2025 8:04:57 AM | View | Financials | Earnings | WIRE | 3Q 2025 | Rev $242,000 | Assets $14,996,000 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/14/2025 4:56:59 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $242,000 | Assets $14,996,000 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/18/2025 4:32:48 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $4,838,000 | Export Earnings Model | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/18/2025 6:12:53 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $4,838,000 | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/21/2025 4:39:08 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $983,000 | Assets $12,956,000 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/15/2025 5:15:21 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $7,590,000 | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 4/30/2025 4:44:43 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Assets $3,651,000 | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 3/21/2025 5:21:53 PM | View | Financials | Earnings | SEC | Y 2024 | Assets $3,651,000 | Export Earnings Model | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 3/14/2025 4:44:41 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $3,651,000 | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/15/2024 5:26:03 PM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $4,462,000 | Export Earnings Model | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/14/2024 4:14:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $4,462,000 | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 9/5/2024 4:25:35 PM | View | Proxy | SEC | Y 2023 | ||||||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/15/2024 6:11:47 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $5,264,000 | Export Earnings Model | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/14/2024 4:46:14 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $5,264,000 | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/16/2024 6:03:57 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $3,788,000 | EPS -$0.74 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/14/2024 4:48:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $3,788,000 | EPS -$0.74 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 4/29/2024 4:54:40 PM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Assets $7,315,000 | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 4/2/2024 6:05:33 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $3,788,000 | EPS -$0.74 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 3/29/2024 5:27:44 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $7,315,000 | |||
| NRX Pharmaceuticals, Inc. (NRXP) | 3/11/2024 5:16:56 PM | View | Proxy | SEC | Y 2023 | ||||||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/22/2023 4:34:48 PM | View | Proxy | SEC | Y 2022 | ||||||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/15/2023 4:03:14 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $13,110,000 | EPS -$0.07 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/14/2023 11:31:27 AM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $13,110,000 | EPS -$0.07 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/14/2023 4:45:45 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $19,809,000 | EPS -$0.12 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/14/2023 4:09:55 PM | View | Financials | Earnings | WIRE | 2Q 2023 | Assets $19,809,000 | EPS -$0.12 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/26/2023 5:14:38 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Assets $25,816,000 | EPS -$0.60 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/16/2023 6:47:58 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $21,780,000 | EPS -$1.66 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/15/2023 5:11:02 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $21,780,000 | EPS -$1.66 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/1/2023 5:33:20 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Assets $25,816,000 | EPS -$0.60 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 3/31/2023 4:38:18 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $25,816,000 | EPS -$0.60 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 3/31/2023 6:31:23 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $25,816,000 | EPS -$0.15 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 1/10/2023 5:31:07 PM | View | Proxy | SEC | Y 2022 | ||||||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/14/2022 4:37:53 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $24,824,000 | EPS -$0.14 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/14/2022 6:52:36 AM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $24,824,000 | EPS -$0.14 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/15/2022 6:20:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $32,433,000 | EPS -$0.11 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/15/2022 6:50:44 AM | View | Financials | Earnings | WIRE | 2Q 2022 | Assets $32,433,000 | EPS -$0.11 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/12/2022 4:57:08 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2021 ending: 9/30/2021 | Assets $45,250,379 | EPS -$0.72 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/12/2022 4:56:17 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2021 ending: 6/30/2021 | Assets $18,546,712 | EPS -$0.41 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 6/21/2022 6:04:11 AM | View | Proxy | SEC | Y 2021 | ||||||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/16/2022 4:40:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $43,601,000 | EPS -$0.21 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 5/16/2022 7:13:17 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Assets $45,250,379 | EPS -$0.72 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 4/29/2022 4:17:58 PM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | Assets $32,729,000 | EPS -$1.98 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 3/31/2022 4:25:52 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $32,729,000 | EPS -$1.98 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 3/31/2022 8:18:01 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Assets $45,250,379 | EPS -$0.72 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/16/2021 5:58:00 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Assets $45,250,379 | EPS -$0.72 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 11/15/2021 4:24:22 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $45,250,379 | EPS -$0.72 | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/16/2021 9:36:02 PM | View | Financials | Earnings | WIRE | 2Q 2021 | Assets $18,546,712 | EPS -$0.41 | Export Earnings Model | ||
| NRX Pharmaceuticals, Inc. (NRXP) | 8/16/2021 5:33:08 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $18,546,712 | EPS -$0.41 | ||
| Big Rock Partners Acquisition Corp. (NRXP) | 5/21/2021 6:15:40 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $13,572,107 | EPS -$0.71 | ||
| Big Rock Partners Acquisition Corp. (NRXP) | 5/14/2021 6:14:55 AM | Micro | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Assets $2,941,169 | EPS -$1.51 | ||
| Big Rock Partners Acquisition Corp. (NRXP) | 4/1/2021 5:43:46 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $2,941,169 | EPS -$1.51 | ||
| Big Rock Partners Acquisition Corp. (NRXP) | 4/1/2021 5:14:22 PM | View | Proxy | SEC | Y 2020 | ||||||
| Big Rock Partners Acquisition Corp. (NRXP) | 12/7/2020 1:31:51 PM | View | Proxy | SEC | Y 2019 | ||||||
| Big Rock Partners Acquisition Corp. (NRXP) | 11/16/2020 5:04:13 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $6,031,775 | EPS -$0.15 | ||
| Big Rock Partners Acquisition Corp. (NRXP) | 8/14/2020 5:05:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $6,277,048 | |||
| Big Rock Partners Acquisition Corp. (NRXP) | 7/10/2020 6:01:54 AM | View | Proxy | SEC | Y 2019 | ||||||
| Big Rock Partners Acquisition Corp. (NRXP) | 5/15/2020 4:35:43 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $6,272,781 | EPS -$0.15 | ||
| Big Rock Partners Acquisition Corp. (NRXP) | 3/30/2020 5:35:41 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $1,205,820 +10.7% | Assets $985,936 | EPS -$0.63 | |
| Big Rock Partners Acquisition Corp. (NRXP) | 3/9/2020 4:01:25 PM | View | Proxy | SEC | Y 2019 | ||||||
| Big Rock Partners Acquisition Corp. (NRXP) | 11/14/2019 4:14:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $258,236 -8.9% | Assets $41,685,076 | EPS -$0.04 | |
| Big Rock Partners Acquisition Corp. (NRXP) | 11/8/2019 6:09:54 AM | View | Proxy | SEC | Y 2018 | ||||||
| Big Rock Partners Acquisition Corp. (NRXP) | 8/14/2019 5:15:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $392,439 +44.0% | Assets $50,102,727 | EPS -$0.03 | |
| Big Rock Partners Acquisition Corp. (NRXP) | 8/9/2019 9:25:55 AM | View | Proxy | SEC | Y 2018 | ||||||
| Big Rock Partners Acquisition Corp. (NRXP) | 5/15/2019 4:35:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $382,862 +79.3% | Assets $71,707,751 | EPS -$0.03 | |
| Big Rock Partners Acquisition Corp. (NRXP) | 5/7/2019 7:28:34 AM | View | Proxy | SEC | Y 2018 | ||||||
| Big Rock Partners Acquisition Corp. (NRXP) | 3/15/2019 5:42:06 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $1,088,915 +3,085.5% | Assets $70,796,159 | EPS -$0.29 | |
| Big Rock Partners Acquisition Corp. (NRXP) | 11/8/2018 5:25:44 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | ||||
| Big Rock Partners Acquisition Corp. (NRXP) | 8/8/2018 5:06:27 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | ||||
| Big Rock Partners Acquisition Corp. (NRXP) | 5/29/2018 4:00:21 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | ||||
| Big Rock Partners Acquisition Corp. (NRXP) | 3/23/2018 4:31:50 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 |